ELUTIA INC. — Director's Dealing 2021

Mar 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AZIYO BIOLOGICS, INC. (AYZO)
CIK: 0001708527
Period of Report: 2021-03-08

Reporting Person: LLOYD RONALD K. (Director, PRESIDENT AND CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-08	STOCK OPTION (RIGHT TO BUY)	$14.53	A	97725	Acquired	2031-03-08	CLASS A COMMON STOCK (97725)	Direct
2021-03-08	RESTRICTED STOCK UNITS	$	A	16288	Acquired		CLASS A COMMON STOCK (16288)	Direct

Footnotes

F1: This option vests as to 25% of the shares on March 8, 2022, and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2025.

F2: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock.

F3: The restricted stock units vest in 4 substantially equal annual installments beginning on March 8, 2022 and have no expiration date.